LEXINGTON, Mass. & SYDNEY--(BUSINESS WIRE)--GI Dynamics, Inc. (ASX: GID) (the Company), a medical device company that provides an innovative treatment for type 2 diabetes and obesity, today announces ...
GI Dynamics officials are still on the down low about their IPO down under, but the company’s offering of more than 72 million shares of stock on the Australian exchange opened yesterday. The ...
BOSTON & SYDNEY--(BUSINESS WIRE)--GI Dynamics, Inc. (ASX:GID), a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the ...
GI Dynamics, Inc., a Lexington, Mass.-based company known for its EndoBarrier Therapy, which it claims can reduce blood-sugar levels and offer weight-loss results in Type 2 Diabetes patients, has ...
GI Dynamics has announced it has received conditional FDA approval to commence a pivotal clinical trial of the company’s EndoBarrier product, according to a news release. EndoBarrier is described as a ...
The French government has signed on to sponsor a cost-effectiveness study of GI Dynamics' EndoBarrier.--Courtesy of GI Dynamics As GI Dynamics ($GID) works toward FDA ...
GI Dynamics added Francesco Rubino, MD, and Philip Schauer, MD, to its scientific advisory board. 1. GI Dynamics is hoping to leverage its board to support its U.S. investigational device exemption ...
The company has a new management team in place, including a chief compliance officer, to fix quality control problems related to the EndoBarrier device. Amanda Pedersen GI Dynamics has faced multiple ...
GI Dynamics is a little-known Massachusetts company with a novel non-surgical endoscopic therapy that causes weight loss. I discovered GI Dynamics (GIDYL) while traveling in Australia in 2011. It's a ...
Micro-cap obesity device company GI Dynamics is restructuring by cutting 10% of its workforce, including its CFO, as well as reviewing its strategic options. The Australian company expects to ...
GI Dynamics Announces Commercial Availability of EndoBarrier® Therapy in Israel for the Treatment of
LEXINGTON, Mass. & SYDNEY--(BUSINESS WIRE)-- GI Dynamics, Inc. (ASX: GID) today announced that The Sheba Medical Center (Tel Hashomer) at Ramat-Gan, Israel, is now offering EndoBarrier ® Therapy, a ...
LEXINGTON, Mass. & CLEVELAND--(BUSINESS WIRE)-- GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that Stuart A. Randle, chief executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results